deltatrials
Completed OBSERVATIONAL NCT03260049

The Necessity and Optimal Time for Performing Pars Plana Vitrectomy in Acute Retinal Necrosis Patients

Sponsor: Chongqing Medical University

Updated 5 times since 2017 Last updated: Aug 21, 2017 Started: Apr 30, 2012 Primary completion: Feb 28, 2017 Completion: Feb 28, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Acute Retinal Necrosis and is currently completed. Chongqing Medical University leads this study, which shows 5 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Sep 2017 – ~Apr 2018 · 7 months · monthly snapshotCompleted~Apr 2018 – ~Jan 2021 · 33 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

5 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2021 — Jul 2024 [monthly]

    Completed

  4. Apr 2018 — Jan 2021 [monthly]

    Completed

    Phase: NANone

  5. Sep 2017 — Apr 2018 [monthly]

    Completed NA

    First recorded

Apr 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Chongqing Medical University
Data source: Chongqing Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.